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Ionotropic glutamate receptors (iGluR) are ligand-gated ion channels and are densely
expressed in broad areas of mammalian brains. Like iGluRs, acid-sensing ion channels
(ASIC) are ligand (H+)-gated channels and are enriched in brain cells and peripheral sen-
sory neurons. Both ion channels are enriched at excitatory synaptic sites, functionally
coupled to each other, and subject to the modulation by a variety of signaling molecules.
Central among them is a gasotransmitter, nitric oxide (NO). Available data show that NO
activity-dependently modulates iGluRs and ASICs via either a direct or an indirect pathway.
The former involves a NO-based and cGMP-independent post-translational modiﬁcation (S-
nitrosylation) of extracellular cysteine residues in channel subunits or channel-interacting
proteins. The latter is achieved by NO activation of soluble guanylyl cyclase, which in turn
triggers an intracellular cGMP-sensitive cascade to indirectly modulate iGluRs and ASICs.
The NO modiﬁcation is usually dynamic and reversible. Modiﬁed channels undergo sig-
niﬁcant, interrelated changes in biochemistry and electrophysiology. Since NO synthesis
is enhanced in various neurological disorders, the NO modulation of iGluRs and ASICs is
believed to be directly linked to the pathogenesis of these disorders. This review summa-
rizes the direct and indirect modiﬁcations of iGluRs and ASICs by NO and analyzes the role
of the NO-iGluR and NO-ASIC coupling in cell signaling and in the pathogenesis of certain
related neurological diseases.
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INTRODUCTION
Ionotropic glutamate receptors (iGluR) are ligand-gated cation
ion channels. They are classiﬁed into N -methyl-d-aspartate
receptors (NMDAR), α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid receptors (AMPAR), and kainate receptors (Din-
gledine et al., 1999). These receptors are densely distributed in
broad regions of the mammalian central nervous system (CNS).
Functional iGluRs are assembled by distinct subunits. Activation
of iGluRs by an endogenous ligand, i.e., neurotransmitter gluta-
mate, opens the channel for the Na+ ﬂow into cells, resulting in
depolarization. NMDARs and GluR2-lacking AMPARs also allow
Ca2+ inﬂux for triggeringmultifunctional Ca2+-associated signal-
ing pathways. Compared to NMDARs, AMPARs open and close
more quickly, and thusmediatemost of the fast excitatory synaptic
transmission in the CNS. As a major group of excitatory recep-
tors, iGluRs are critical for normal operations of cellular and
synaptic activity and plasticity. Malfunction of these ion chan-
nels is thus frequently linked to the pathogenesis of a wide range
of neurological disorders (Dingledine et al., 1999).
Neuronal cells are sensitive to changing extracellular pro-
ton (acid) concentrations. In sensory neurons, an acid-triggered
inward ion current was ﬁrst observed in 1980 (Krishtal and Pido-
plichko, 1980). This current was then found to be mediated
through the membrane-bound acid-sensing ion channel (ASIC;
Waldmann et al., 1997b). ASICs are a distinct family of pro-
ton (H+)-gated, voltage-independent, and cation (Na+)-selective
channels. They are broadly expressed in peripheral sensory neu-
rons and CNS neurons (Waldmann et al., 1997a,b; Alvarez de la
Rosa et al., 2003).More speciﬁcally, among all ASIC subunits so far
identiﬁed, ASIC1a, 2a, and 2b are expressed in CNS neurons at a
high level,while all otherASICs are expressed in peripheral sensory
neurons. In addition,ASICs are seen in non-neuronal cells, such as
vascular smooth muscles and bone (Jahr et al., 2005; Grifoni et al.,
2008). ASICs are important for maintaining cell homeostasis in
response to normal changes in pH signals and are involved in dis-
crete disorders where a dramatic drop in extracellular pH values
(acidosis) occurs, such as seen in inﬂammation, ischemic stroke,
traumatic brain injury, and acid nociception (Wemmie et al., 2006;
Chu et al., 2011).
Like many other ion channels, iGluRs and ASICs are subject
to the modulation by various extracellular and intracellular sig-
nals. This modulation is essential for normal channel operations
and for adjusting the efﬁcacy and strength of channels to prop-
erly respond to a given stimulus. Among important modulators is
nitric oxide (NO), a short-lived and plasma membrane diffusible
gasotransmitter. Increasing evidence shows that NO can mod-
ulate iGluRs and ASICs through a direct (cGMP-independent)
or an indirect (cGMP-dependent) pathway (Ahern et al., 2002).
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The direct pathway involves a NO-based post-translational mod-
iﬁcation of iGluR and ASIC proteins, i.e., S-nitrosylation. This
biochemical reaction occurs when a nitrosyl group is added to
the thiol side-chain of cysteine residues to form S-nitrosothiols,
leading to changes in tertiary structure and function of modiﬁed
iGluRs and ASICs (Sen and Snyder, 2010). The indirect pathway
starts with NO stimulation of soluble guanylyl cyclase, leading to
an increase in the second messenger cGMP production and acti-
vation of cGMP-dependent downstream protein kinases (Bredt
and Snyder, 1989). This review will discuss current progress in
understanding the modulation of iGluRs and ASICs by NO. We
reviewed these two types of channels together because (1) they are
co-localized in the conﬁned postsynaptic density microdomain
(Zha et al., 2006), (2) they are functionally coupled to each other
to contribute to neurological disorders involving excessive gluta-
mate release and acidosis (Gao et al., 2005), and (3) they show
some common properties in the regulation by NO.
MODULATION OF iGluRs BY NO
NMDARs
TheNMDAR is a unique ion channel that is both ligand-gated and
voltage-dependent. Co-activation of NMDARs by the endogenous
transmitters (glutamate and glycine) and the release of voltage-
dependentMg2+ block trigger the opening of ion channels, allow-
ing the inward ﬂow of Na+ and small amounts of Ca2+ into cells
(Dingledine et al., 1999). The Ca2+ inﬂux is critical for a variety
of NMDAR signaling and function. Functional NMDARs are an
assembly of obligatory NR1 and the modulatory NR2 subunits.
Among all of the modulatory subunits (A–D), NR2A and NR2B
are predominant NMDAR components and are mostly enriched
in neurons (Stephenson, 2001).
NMDARs are closely linked to the NO system. Activation of
NMDARs consistently increases activity of neuronal nitric oxide
synthase (nNOS) in the cytoplasm of neurons. Active nNOS then
catalyzes the production of endogenous NO from l-arginine,
leading to an increased release of NO from neurons (Garth-
waite et al., 1988; Shibuki and Okada, 1991; Bredt and Snyder,
1992). A number of studies in vitro and in vivo have demon-
strated a signiﬁcant role of NO in the regulation of normal
NMDAR function. In cultured neurons, the NO-producing agent
3-morpholino-sydnonimine (SIN-1) inhibited NMDA-induced
currents and associated increases in Ca2+ inﬂux (Manzoni et al.,
1992). Similar results were observed with 1-nitrosopyrrolidine
(an NO-containing agent) and NaNO2 (a released form of NO),
while NO scavenging by hemoglobin reversed the effect of these
agents (Manzoni et al., 1992). Endogenous NOS activity in cul-
tured striatal neurons is also closely linked to NMDAR activity.
The natural substrate of NOS, l-arginine, diminished NMDAR
activity, which was reversed by the NOS inhibitor l-nitroarginine
(Manzoni and Bockaer, 1993). In channel recordings from rat
cortical neurons or Xenopus oocytes, the NO-generating agent
S-nitrosocysteine (SNOC) decreased NMDAR channel opening
(Lei et al., 1992; Lipton et al., 1998) or NMDA-evoked currents
(Omerovic et al., 1995; Choi et al., 2000). Similar to the in vitro
results, an in vivo microdialysis study showed that the NO donor
S-nitroso-N -acetylpenicillamine (SNAP) suppressed the NMDA-
stimulated NO release in the rat striatum (Kendrick et al., 1996).
Together, in vitro and in vivo data support an inhibitory modu-
lation of NMDARs by NO under normal conditions. Given that
NMDAR stimulation increases NO synthesis, NO and NO-related
species serve as key regulators in a use-dependent negative feed-
back mechanism to prevent excessive NMDAR activation and to
maintain the receptor activity at the physiological level (Choi et al.,
2000).
The mechanism underlying the NO modulation of NMDARs
seems to involve a direct and cGMP-independent pathway. It has
been found that NMDARs can be directly modiﬁed by a bio-
chemical reaction, S-nitrosylation. S-nitrosylation is an important
biological reaction of NO and is a key post-translational modiﬁ-
cation for multiple ion channels (Hess et al., 2005). Such mod-
iﬁcation adds a nitrosyl group (NO+) to the thiol side-chain of
cysteine residues to form S-nitrosothiols, leading to a reversible
change in tertiary structure and function of modiﬁed proteins
(Sen and Snyder, 2010). In dissecting a molecular mechanism for
the NO-NMDAR coupling, a single cysteine residue (C399) in the
extracellular N terminus of NR2A was found to account for the
predominant effect of NO. This cysteine can be physiologically
S-nitrosylated after NO+ transfer, and site-directed mutation of it
to alanine abolished the NO-mediated inhibition of NR1/NR2A
receptors (Choi et al., 2000). Thus, C399 S-nitrosylation serves
as an important pathway linking NO to NMDARs. Additionally,
two pairs of cysteine residues on NR1 (C744, C789) and NR2A
(C87, C322) could undergo S-nitrosylation and thereby inhibit
NMDARs if they are in the free thiol form (Choi et al., 2000,
2001; Lipton et al., 2002). Of note, nNOS forms a complex with
NR1 via a scaffolding protein PSD-95 in the postsynaptic den-
sity microdomain (Brenman et al., 1996). Co-localization of these
proteins at deﬁned synaptic sites facilitates their direct interac-
tions and enables rapid feedback inhibition of NMDARs via a
NO-sensitive mechanism.
NO can also indirectly modulate NMDARs through S-
nitrosylating the prime regulators of NMDARs. Serine racemase
(SR) is an enzymewhich converts l-serine tod-serine, a co-agonist
with glutamate at NMDARs. It has been shown that SR is phys-
iologically S-nitrosylated for marked inhibition of the enzyme
(Mustafa et al., 2007). This S-nitrosylation was enhanced by
NMDAR-activated nNOS. Thus, postsynaptic stimulation of NO
formation possibly feeds back to presynaptic cells to S-nitrosylate
SRanddecreased-serine availability. This contributes to inhibiting
excitatory synaptic transmission and preventing overstimulation
of postsynaptic NMDARs. PSD-95 is a principal scaffolding pro-
tein at synaptic sites where it determines the number of NMDARs
and thus efﬁciency and strength of the receptor. It also couples
NMDARs to nNOS to form signalosomes for local NO produc-
tion. Like SR, PSD-95 is physiologically S-nitrosylated (Ho et al.,
2011). S-nitrosylation occurs at two speciﬁc cysteines (C3 and
C5). Interestingly, these sites are also subject to palmitoylation,
another reversible and cysteine-based post-translational modiﬁ-
cation which covalently attaches a fatty acid (palmitic acid) to
cysteine (Ho et al., 2011). In cerebellar neurons, NO inhibited
PSD-95 palmitoylation and decreased synaptic delivery of PSD-
95. In heterologous cells, decreased palmitoylation resulted in
increased PSD-95 S-nitrosylation (Ho et al., 2011). These data
support a model in which NMDARs stimulate NO to regulate
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PSD-95 via mutually competitive cysteine modiﬁcations. Regu-
lated PSD-95 then reciprocally controls expression and activity of
NMDARs.
Normal NMDAR activity is important for cell signaling and
synaptic plasticity. Excessive activation of the receptor, however,
results in excitotoxity and cell death. To this end, NMDARs are
crucial for neuronal survival in various neurodegenerative dis-
orders (Lipton and Rosenberg, 1994). Since NO inhibits exces-
sive stimulation of NMDARs, it could consequently ameliorate
NMDAR-mediated neurotoxicity. Of note, both NMDAR and NO
activities are upregulated in parallel during neurological disorders
such as ischemia, trauma, and inﬂammation. As such, they both
are actively involved in resultant neuronal death under these neu-
rodegenerative conditions (Dawson et al., 1993; Bonfoco et al.,
1995). Indeed, hypoxia renders NMDARs exquisitely sensitive to
NO-induced S-nitrosylation and inhibition of NMDARs in corti-
cal neurons and oocytes (Takahashi et al., 2007). Such enhanced
NO inhibition of NMDARs is thought to be neuroprotective and
serves as a mechanism to counteract NMDAR-mediated cytotox-
icity in hypoxia insults (Lei et al., 1992; Lipton et al., 1993; Choi
et al., 2000; Takahashi et al., 2007). In addition, a large increase
in NO levels in rat brains was discovered immediately after mid-
dle cerebral artery occlusion (Malinski et al., 1993). A higher level
of NO, through the NO-mediated vasodilation, can increase cere-
bral blood ﬂow and oxygen delivery (Toda et al., 2009). This, in
concert with the NO inhibition of NMDARs, protects brain tis-
sue during focal ischemia, although neuronal overproduction of
NO may elicit neurotoxicity (Dalkara et al., 1994). The inhibitory
control of NMDARs by NO has potential clinical implications.
Pharmacotherapies targeting nitrosylatable cysteine residues can
be developed to prevent NMDAR-mediated neurotoxicity during
stroke (Takahashi et al., 2007).
AMPARs
AMPARs are another important glutamate ion channel. Like
NMDARs, AMPARs become functional upon a heterotetrameric
assembly of four subunits (GluR1–4 or GluRA–D; Dingledine
et al., 1999). Most AMPARs contain symmetric “dimer of dimers”
of GluR2 and either GluR1, GluR3, or GluR4 (Greger et al.,
2007). Activation of these receptors promotes Na+ inﬂux and
induces rapid depolarization.AMPARs open and close quickly and
thus carry out the most of fast excitatory synaptic transmission
in the CNS.
Little is known about whether AMPAR subunits are direct tar-
gets of NO.However, several keyAMPAR-interacting proteins that
actively control AMPAR trafﬁcking, expression, and function are
S-nitrosylated and regulated by NO. N -ethylmaleimide sensitive
factor (NSF) is an ATPase enriched in neurons. It binds to GluR2
(Nishimune et al., 1998; Osten et al., 1998; Song et al., 1998),
stabilizing or recycling AMPARs into postsynaptic membranes
(Braithwaite et al., 2002; Lee et al., 2002). It was found that synaptic
NSFwas physiologically S-nitrosylated by endogenous, neuronally
derived NO in mouse brain (Huang et al., 2005). NMDAR activa-
tion enhanced NSF S-nitrosylation and thereby augmented NSF
binding toGluR2 and surface insertion of GluR2. These data reveal
a NO-sensitive pathway linking NMDARs to AMPARs. Speciﬁ-
cally, NMDARs, through activating associated nNOS, trigger NO
formation, which upregulates NSF S-nitrosylation to promote
its associations with GluR2 and increase surface expression of
GluR2-containing AMPARs (Huang et al., 2005). In this process,
PICK1 (protein interacting with C kinase 1), a synaptic anchor-
ing protein binding and retaining GluR2 in intracellular pools,
seems tomediate the NSF regulation of GluR2. S-nitrosylatedNSF
can dissemble the PICK1-GluR2 complex, leading to a release of
GluR2 from PICK retention and subsequent surface delivery of
GluR2/AMPARs (Hanley et al., 2002; Sossa et al., 2007).
Stargazin is another synaptic protein that linksNO toAMPARs.
As a founding member of the transmembrane AMPAR regulatory
protein (TARP) family, stargazin serves as an auxiliary subunit of
all AMPAR subtypes and directly interacts with a large part of
AMPARs. As such, stargazin is thought to be a principal determi-
nant of AMPARsurface expression. Indeed,Snyder and co-workers
showed that stargazin, like NSF, is physiologically S-nitrosylated
at C302 in primary neurons and heterologous cells (Selvakumar
et al., 2009). S-nitrosylation of stargazin was positively linked to
surface expression of this small tetraspanning membrane pro-
tein. S-nitrosylation also increased binding of stargazin to the
AMPAR subunit GluR1, causing upregulated surface expression
of the AMPAR. NMDAR stimulation increased S-nitrosylation
of stargazin and binding of stargazin to AMPARs. Apparently,
stargazin, like NSF, is a physiological regulator of AMPARs and a
linker between NMDARs and AMPARs. Through a NO-sensitive
mechanism, stargazin transmits NMDAR signals to the level of
surface expression of AMPARs.
In addition to S-nitrosylation, NO stimulates soluble guanylyl
cyclase to form the second messenger cGMP (Bredt and Snyder,
1989). Thus, cGMP and downstream protein kinases could con-
stitute an indirect pathway to regulate AMPARs. A recent study
supports this notion (Serulle et al., 2007). In this study, the cGMP-
dependent kinase type II (cGKII), a distinct GK isoform located in
cellular membranes and broadly expressed in the brain (Fran-
cis and Corbin, 1999), was found to directly bind to GluR1.
This binding was sensitive to nNOS activity and cGMP. More-
over, the binding enables the kinase to phosphorylate GluR1 at
an intracellular serine site (S845). In cultured hippocampal neu-
rons, active cGKII accumulated GluR1 on the plasma membrane
at extrasynaptic sites. Blockade of cGKII prevented this accumu-
lation and also an increase in mEPSC frequency and amplitude.
Of note, S845 was also phosphorylated by protein kinase A (PKA),
which was required for GluR1 synaptic insertion (Esteban et al.,
2003). Thus, both cGKII and PKA pathways converge on S845 to
regulate its phosphorylation and the phosphorylation-dependent
GluR1 insertion into the surface membrane. It is believed that the
two pathways operate in concert and in distinct temporospatial
manners to modulate synaptic plasticity.
MODULATION OF ASICs BY NO
In addition to glutamate receptor channels, ASICs represent
another family of ion channels subjected to the modulation by
NO. Seven subunits of ASICs (1a, 1b1, 1b2, 2a, 2b, 3, and 4) have
been identiﬁed to date, which are encoded by four genes (Price
et al., 1996; Lingueglia et al., 1997;Waldmann et al., 1997a,b; Chen
et al., 1998; Akopian et al., 2000). A major function of ASICs is
to maintain normal cellular activity in response to changing pH
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signals. Given the fact that a variety of neurological disorders,
including inﬂammation, ischemic stroke, traumatic brain injury
and acid nociception, cause severe acidosis, ASICs are deemed to
be activated and play a role in cell death and in the pathogenesis
or progression of these diseases (Wemmie et al., 2006; Chu et al.,
2011). As a result, ASICs are emerging as new pharmacotherapeu-
tic targets for these illnesses (Wemmie et al., 2006; Xiong et al.,
2008; Sluka et al., 2009; Xu and Duan, 2009).
Acid-sensing ion channels are subject to the regulation by
various extracellular and intracellular signals (Chu et al., 2011).
Among the known regulators is NO. It has been suggested
that ASICs are a potential target for direct modulation by NO-
dependent S-nitrosylation (Cadiou et al., 2007). This is based on
the facts that (1) the channel possesses a large number of cys-
teine residues on their extracellular domains (Waldmann et al.,
1999), and (2) oxidizing agents, 5,5′-dithio-bis-(2-nitrobenzoic
acid; DTNB), showed a sizable impact on acid-evoked currents in
neurons and heterologous cells (Andrey et al., 2005; Chu et al.,
2006). In support of this, Cadiou et al. (2007) reported that the
NOdonor SNAPpotentiated proton-gated currents in rat cultured
dorsal root ganglion (DRG) neurons and in CHO cells expressing
each of ASIC subunits. The SNAP effect was not due to activa-
tion of the cGMP pathway because the cGMP analog db-cGMP
did not mimic, and the guanylyl cyclase inhibitor ODQ did not
block, the SNAP potentiation. The effect of SNAP was thought to
be mediated via a direct mechanism involving NO S-nitrosylation
at extracellular cysteines of ASICs (Cadiou et al., 2007).
Acid-sensing ion channels are known to participate in medi-
ating acid-evoked pain in humans. This process is believed to be
regulated by NO, based on the ﬁnding that topical application of
an NO donor enhanced acid-evoked pain (Cadiou et al., 2007).
Another neurological disorder in which the NO potentiation of
ASICs may have a pathophysiological relevance is ischemia. Cere-
bral ischemia is known to cause metabolic acidosis. This leads
to activation of ASICs, especially Ca2+ permeable ASIC1a, which
increases intracellular Ca2+ overload and results in neuronal death
(Xiong et al., 2004).NOpromoted suchneuronal death by potenti-
atingASICs duringmild andmoderate acidosis, although in severe
acidosis NO synthesis was inhibited and the NO contribution
subsided (Jetti et al., 2010).
CONCLUSION
Ionotropic glutamate receptors have long been appreciated to
be subject to various types of post-translational modiﬁcations
which determine expression, trafﬁcking, and function of modiﬁed
receptors. NO-dependent S-nitrosylation is one of these modi-
ﬁcations. Available data show that NMDARs are directly mod-
ulated by NO-mediated S-nitrosylation. Direct S-nitrosylation
occurs at a cysteine site (C399) in an extracellular N-terminal
region of NR2A subunits. In addition to NR2A, NO inﬂuences
other synaptic proteins that are important for NMDAR activ-
ity. Serine racemase which generates d-serine, a co-agonist of
NMDARs, is S-nitrosylated. The S-nitrosylation inhibits its enzy-
matic activity. PSD-95, a scaffolding protein stabilizing NMDARs
at synaptic sites and linking nNOS to NMDARs, also undergoes
physiological S-nitrosylation, which suppresses synaptic delivery
of PSD-95. Apparently, the NO regulation of all three elements
(NR2A, serine racemase, and PSD-95) can synergistically gener-
ate an inhibitory driving force on NMDARs. Given that NMDARs
stimulate NO synthesis, NO forms a negative feedback loop to
prevent overstimulation of the receptor.
Direct S-nitrosylation of AMPARs has not been reported.
Instead, AMPAR-interacting proteins are S-nitrosylated and regu-
lated by NO. NSF binds to AMPAR GluR2, while stargazin binds
to GluR1. NMDAR activation enhances S-nitrosylation of both
proteins, facilitating their binding to GluR1/2 and surface expres-
sion of AMPARs. In addition to this S-nitrosylation-dependent
and cGMP-independent mechanism, the cGMP-dependent path-
way also mediates the NO regulation of AMPARs. Like gluta-
mate ion channels, ASICs are modulated by NO. NO is believed
to potentiate ASIC activity. This potentiation was not medi-
ated by the cGMP-dependent pathway, but mediated through
S-nitrosylation of extracellular cysteines of ASICs. The NO poten-
tiation of ASICs contributes to acid-evoked pain and ischemia-
induced neuronal death. It is possible that all NO targets, including
NMDARs, AMPARs, ASICs, and their associated proteins, can
be co-localized at same subsets of synapses. NO could there-
fore simultaneously regulate these synaptic proteins and inter-
actions among them to precisely control synaptic transmission.
It is anticipated that NO modiﬁcation biology of ion chan-
nels will grow rapidly and more sophisticated NO modiﬁcation
models on glutamate ion channels and ASICs will be character-
ized in vivo. Ultimately, this knowledge will be translated into
novel and effective pharmacotherapies for respective neurological
disorders.
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